(Q58448995)

English

The Inhibitory Effect of Glucagon-Like Peptide-1 (7-36)amide on Antral Motility is Antagonized by Its N-Terminally Truncated Primary Metabolite GLP-1 (9-36)amide

scientific article published on 01 January 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663453%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

The inhibitory effect of glucagon-like peptide-1 (7-36)amide on antral motility is antagonized by its N-terminally truncated primary metabolite GLP-1 (9-36)amide (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663453%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

primary metabolite

1 reference

based on heuristic

inferred from title

Morten Wøjdemann

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663453%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Jens Juul Holst

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663453%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

author name string

A Wettergren

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663453%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

publication date

1 January 1998

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663453%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663453%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663453%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663453%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

877-882

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663453%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Exon duplication and divergence in the human preproglucagon gene

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900020-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900020-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucagon-like peptide 1 undergoes differential tissue-specific metabolism in the anesthetized pig

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900020-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900020-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucagon-like peptide-1(7-36)amide: characterization of the domain responsible for binding to its receptor on rat insulinoma RINm5F cells

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900020-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Potential therapeutic levels of glucagon-like peptide I achieved in humans by a buccal tablet

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900020-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900020-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900020-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucagonlike peptide 1: a newly discovered gastrointestinal hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900020-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucagon-like peptide-1-(9-36) amide is a major metabolite of glucagon-like peptide-1-(7-36) amide after in vivo administration to dogs, and it acts as an antagonist on the pancreatic receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900020-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Ileal release of glucagon-like peptide-1 (GLP-1)

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900020-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900020-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulinotropic action of glucagonlike peptide-I-(7-37) in diabetic and nondiabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900020-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucagon-like peptide-1 (7-36)-NH2: a physiological inhibitor of gastric acid secretion in man

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900020-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucagon-Like Peptides GLP-1 and GLP-2, Predicted Products of the Glucagon Gene, Are Secreted Separately from Pig Small Intestine but Not Pancreas*

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900020-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900020-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Secretion of the Incretin Hormones Glucagon-Like Peptide-1 and Gastric Inhibitory Polypeptide Correlates with Insulin Secretion in Normal Man Throughout the Day

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900020-5

7 January 2021

based on heuristic

inferred from DOI database lookup

GLP-1 (glucagon-like peptide 1) and truncated GLP-1, fragments of human proglucagon, inhibit gastric acid secretion in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900020-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucagon-like peptide-1 7-36 amide and peptide YY have additive inhibitory effect on gastric acid secretion in man

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900020-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucagon-like peptide-1 7-36 amide and peptide YY from the L-cell of the ileal mucosa are potent inhibitors of vagally induced gastric acid secretion in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900020-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900020-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0196-9781(98)00020-5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663453%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663453%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58448995&oldid=1762011058"